149 results
Page 2 of 8
8-K
EX-10.1
qorb7mgs3slx7
30 Jan 24
SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market
9:18am
8-K
EX-99.1
hu6oer od
30 Jan 24
SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market
9:18am
8-K
EX-99.1
10xpjq31l7c
11 Jan 24
SeaStar Medical Appoints David A. Green as Chief Financial Officer
4:10pm
S-3
dxm7xi vfdkaz83t3w
1 Dec 23
Shelf registration
4:06pm
8-K
EX-99.1
fd9 va5obesiu851u5v
21 Nov 23
SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update
6:04pm
8-K
EX-99.1
2su5cv3nr58nn
30 Oct 23
FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients
8:15am
424B3
fa151kp uwch6
6 Oct 23
Prospectus supplement
1:08pm
424B3
v37z8vktjya
6 Oct 23
Prospectus supplement
1:06pm
424B3
5j70kdrithkbx c5
6 Oct 23
Prospectus supplement
1:04pm
424B3
pyp2vx m5ijl5
6 Oct 23
Prospectus supplement
12:59pm
8-K
EX-99.1
pn7wkv6h lpu0l
3 Oct 23
Company to finalize labeling with FDA Approvable Letter expected within a month
4:07pm
8-K
EX-9.1
nhzmjy65
24 Aug 23
Regulation FD Disclosure
5:15pm
424B3
3ke6aqe6v66zowttd
15 Aug 23
Prospectus supplement
4:45pm
424B3
qiaqv33a8nhlr8a
15 Aug 23
Prospectus supplement
4:43pm
424B3
jfpf88 6evjahv3bm
15 Aug 23
Prospectus supplement
4:41pm